Sertraline, which is indicated for the treatment of Panic Disorder, PTSD, and Social Anxiety Disorder in adults and OCD in adults and children is now available in the new strength of 25mg tablets.
Luke Hart, General Manager comments, “we know that the 25mg dose is the starting dose for a number of indications, so we hope that the launch of this new strength will provide greater flexibility when titrating upwards and stepping down, when coming off medication”.
He adds that this new launch is reflective of Zentiva’s continuing approach to invest in niche generics – in order to better meet patients’ needs.
For more information contact zentiva.specialty@zentiva.com
About Zentiva
Zentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites – including flagship sites in Prague, Bucharest and Ankleshwar – Zentiva strives to be the champion of branded and generic medicines in Europe to better support people’s daily healthcare needs.
At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on.
Learn more about Zentiva on www.zentiva.co.uk
